| Literature DB >> 33221863 |
Paulo Ernando Ferraz Cavalcanti1,2, Michel Pompeu Barros Oliveira Sá1,2, Ricardo Felipe de Albuquerque Lins1, Catarina Vasconcelos Cavalcanti1, Ricardo de Carvalho Lima1,2, Tomislav Cvitkovic3, Dmitry Bobylev3, Dietmar Boethig3,4, Philipp Beerbaum4, Samir Sarikouch3, Axel Haverich3, Alexander Horke3.
Abstract
OBJECTIVES: Our goal was to compare results between a standard computed tomography (CT)-based strategy, the 'three-step preoperative sequential planning' (3-step PSP), for pulmonary valve replacement in repaired tetralogy of Fallot versus a conventional planning approach.Entities:
Keywords: Computed tomography; Pulmonary valve replacement; Surgical planning; Tetralogy of Fallot; Three-step preoperative sequential planning
Year: 2020 PMID: 33221863 PMCID: PMC7954262 DOI: 10.1093/ejcts/ezaa346
Source DB: PubMed Journal: Eur J Cardiothorac Surg ISSN: 1010-7940 Impact factor: 4.191
Figure 1:Volume-rendered sample images of the three-step preoperative sequential planning. Step 1: planning the mediastinal re-entry: panel (A) shows the surgeon’s view and panel (B), the substernal anatomy. Step 2: planning the arterial and venous cannulation for cardiopulmonary bypass: panel (C) shows the ascending aorta and panel (D), a 90° rotation in the longitudinal axis; panel (E) shows the right atrium and (F), a 90° rotation in the longitudinal axis. Step 3: planning the pulmonary valve replacement: panel (G) shows the surgeon’s view of the main pulmonary artery and the right ventricular outflow tract; panel (H) shows a 90° rotation in the longitudinal axis.
Preoperative characteristics: univariate analysis of categorical data
| Variables | 3-Step PSP ( | Conventional planning ( | Total sample ( | |
|---|---|---|---|---|
| Gender | ||||
| Male | 7(50) | 40 (59) | 47 (57) | |
| Female | 7(50) | 28 (41) | 35 (43) | |
| Age range (years) | ||||
| <6 | 7 (10) | 7 (8) | ||
| 6–12 | 4 (29) | 22 (32) | 26 (32) | |
| 13–18 | 2 (14) | 16 (24) | 18 (22) | |
| >19 | 8 (57) | 23 (34) | 31 (38) | |
| Weight range (kg) | ||||
| <10 | 2 (3) | 2 (2) | ||
| 10–20 | 1 (7) | 8 (12) | 9 (11) | |
| 21–80 | 12 (86) | 51 (75) | 63 (77) | |
| >81 | 1 (7) | 7 (10) | 8 (10) | |
| Diagnosis | ||||
| TOF/PS | 6 (43) | 34 (50) | 40 (49) | |
| TOF/PA | 5 (7) | 5 (6) | ||
| TOF/DORV | 6 (9) | 6 (7) | ||
| TOF/AVSD or TOF/APV or post-Rastelli or post-Ross | 2 (14) | 16 (24) | 18 (22) | |
| VSD/PS or PS/PI | 6 (43) | 7 (10) | 13 (16) | |
| Previous operations | ||||
| 1 | 12 (86) | 38 (56) | 50 (61) | |
| 2 | 2 (14) | 18 (26) | 20 (24) | |
| 3 or more | 12 (18) | 12 (15) | ||
| Previous interventional catheter procedures | ||||
| 0–1 | 13 (93) | 48 (70) | 61 (75) | |
| 2 | 10 (15) | 10 (12) | ||
| 3 or more | 1 (7) | 10 (15) | 11 (13) |
Pearson’s χ2 test.
Fisher’s exact test.
Statistically significant (P < 0.05).
PS/PI: pulmonary stenosis and insufficiency; TOF/APV: tetralogy of Fallot with absent pulmonary valve; TOF/AVSD: tetralogy of Fallot associated with atrioventricular septal defect; TOF/DORV: double outlet right ventricle Fallot type; TOF/PA: tetralogy of Fallot with pulmonary atresia; TOF/PS: tetralogy of Fallot with pulmonary stenosis; VSD/PS: ventricular septal defect with pulmonary stenosis.
Preoperative characteristics: univariate analysis of numerical data
| Variables | 3-Step PSP ( | Conventional planning ( | Total sample ( | |
|---|---|---|---|---|
| Age (years) | ||||
| <18 | 12.8 ± 4.5 | 10.5 ± 5.3 | 10.7 ± 5.2 | |
| (11.8) | (10) | (10.2) | ||
| >18 | 32.6 ± 7.1 | 34.9 ± 15.8 | 34.3 ± 14 | |
| (32.3) | (29.9) | (29.9) | ||
| Valve size (mm) | 26 ± 3 | 24 ± 4 | 24 ± 4 | |
| (25) | (24) | (24) | ||
| BSA (m2) | 1.7 ± 0.4 | 1.4 ± 0.5 | 1.4 ± 0.5 | |
| (1.7) | (1.5) | (1.5) | ||
Mann–Whitney U-test.
Statistically significant (P < 0.05).
BSA: body surface area; SD: standard deviation.
Intraoperative characteristics: univariate analysis of categorical data
| Variables | 3-Step PSP ( | Conventional planning ( | Total sample ( | |
|---|---|---|---|---|
| Bypass temperature (°C) | ||||
| >35 | 4 (29) | 5 (7) | 9 (11) | |
| 32–35 | 2 (14) | 16 (24) | 18 (22) | |
| 28–32 | 6 (43) | 21 (31) | 27 (33) | |
| <28 | 2 (14) | 26 (38) | 28 (34) | |
| Valve type | ||||
| TE homograft | 12 (86) | 47 (69) | 59 (72) | |
| Homograft | 2 (14) | 9 (13) | 11 (13) | |
| Contegra® | 4 (6) | 4 (5) | ||
| Hancock® | 6 (9) | 6 (7) | ||
| RVOT conduit | 1 (1.5) | 1 (1) | ||
| Vascutek RVOT ElanConduit® | 1 (1.5) | 1 (1) | ||
| Maze procedure | ||||
| Yes | 4 (6) | 4 (5) | ||
| No | 14 (100) | 64 (94) | 78 (95) | |
| PA or PA branches arterioplasty | ||||
| Yes | 2 (14) | 16 (24) | 18 (22) | |
| No | 12 (86) | 52 (76) | 64 (78) | |
| Tricuspid valve plasty | ||||
| Yes | 1 (7) | 10 (15) | 11 (13) | |
| No | 13 (93) | 58 (85) | 71 (87) | |
| Concomitant procedures | ||||
| 0 | 10 (71) | 38 (56) | 48 (58) | |
| 1 | 3 (21) | 22 (32) | 25 (31) | |
| 2 | 1 (7) | 6 (9) | 7 (9) | |
| 3 | 1 (1.5) | 1 (1) | ||
| 4 | 1 (1.5) | 1 (1) | ||
| Unplanned events | ||||
| 0 | 12 (86) | 57 (84) | 69 (84) | |
| 1 | 2 (14) | 9 (13) | 11 (13) | |
| 2 | 2 (3) | 2 (3) |
Fisher’s exact test.
The need to repeat any surgical movement (for example, the changing cannulation site for the bypass) was also considered.
Statistically significant (P < 0.05).
PA: pulmonary artery; RVOT: right ventricular outflow tract; TE: tissue-engineered.
Intraoperative characteristics: univariate analysis of numerical data
| Variables | 3-Step PSP ( | Conventional planning ( | |
|---|---|---|---|
| Skin-to-CPB time (min) (skin incision to CPB) | 73 ± 25 | 89 ± 32 | |
| (77) | (90) | ||
| CPB time (min) | 145 ± 57 | 186 ± 94 | |
| (126) | (164) | ||
| CPB-to-skin time (min) (from end of CPB to skin closure) | 68 ± 28 | 73 ± 25 | |
| (63) | (69) | ||
| Total time (min) (skin incision to skin closure) |
285 ± 71 (268) |
348 ± 107 (318) | |
| Cross-clamp time (min) | 74 ± 33 | 108 ± 47 | |
| (57) | (89) |
Mann–Whitney U-test.
Statistically significant (P < 0.05).
CPB: cardiopulmonary bypass; SD: standard deviation.
Figure 2:Conventional planning versus 3-step PSP. Box-and-whiskers plots of operative times in min. Each pair of box plots shows the distribution of the measures. The line in the middle of the box indicates the median. The first (Q1) and third (Q3) quartiles are the lower and upper edges of the box, respectively. The upper and lower whiskers show ±1.5 times IQR. The mild (farther than 1.5 times IQR) and the extreme (farther than 3.0 times IQR) outliers are shown as dots and asterisks, respectively. Because the number of measurements is <15 in the 3-step PSP group, each of the data points is plotted as a differently coloured dot. Median comparisons between the 3-step PSP and the conventional planning groups were made according to Mann–Whitney (statistical significance at P < 0.05). 3-Step PSP: three-step preoperative sequential planning; CPB: cardiopulmonary bypass; IQR: interquartile range.
Intraoperative characteristics: matched comparison analysis
| Variables | 3-Step PSP ( | Conventional planning ( | |
|---|---|---|---|
| Lowest temperature in CPB (°C) | 31 ± 4 | 28 ± 5 | |
| (31) | (29) | ||
| Valve size (mm) | 26 ± 3 | 25 ± 3 | |
| (26) | (24) | ||
| Skin-to-CPB time (min) (skin incision to CPB) | 80 ± 21 | 97 ± 27 | |
| (78) | (99) | ||
| CPB time (min) | 123 ± 34 | 190 ± 43 | |
| (113) | (187) | ||
| CPB-to-skin time (min) (from end of CPB to skin closure) | 61 ± 11 | 73 ± 15 | |
| (61) | (68) | ||
| Total time (min) (skin incision to skin closure) |
263 ± 44 (261) |
360 ± 66 (351) | |
| Cross-clamp time (min) | 62 ± 14 | 83 ± 30 | |
| (56) | (77) | ||
| Postoperative length of stay (days) | 8 ± 5 | 13 ± 11 | |
| (6) | (8) |
Wilcoxon test (paired samples).
Statistically significant (P < 0.05).
CPB: cardiopulmonary bypass; SD: standard deviation.